Steven Batki, MD

Professor Emeritus
+1 415 221-4810 ext. 23671

Steven L. Batki, M.D. is Professor of Psychiatry, in Residence, at the University of California, San Francisco (UCSF) School of Medicine and Chief of the Addiction Recovery Treatment Services and Director of the Addiction Psychiatry Research Program at the San Francisco VA Medical Center (SFVAMC), where he also directs the UCSF Addiction Psychiatry Fellowship Program.

Dr. Batki is engaged in addiction research, training, and clinical services. Dr. Batki’s research and clinical interests include pharmacologic treatment for addiction to alcohol, opioids, and stimulants. His work focuses on psychiatric and medical disorders that co-occur with addiction, such as such as PTSD, traumatic brain injury (TBI), schizophrenia, and HIV/HCV. He has published extensively on clinical research in addiction and co-occurring disorders. He chaired the SAMSHA CSAT Treatment Improvement Protocol No. 37, Substance Abuse Treatment for Persons with HIV/AIDS, and Treatment Improvement Protocol No. 43, Medication-Assisted Treatment for Opioid Dependence.

Dr. Batki's current research is supported by the Department of Defense and NIDA. His DoD projects are examining the effectiveness of pharmacotherapy for alcohol use disorders in veterans with posttraumatic stress disorder (PTSD) as well as in veterans with mild traumatic brain injury (TBI). Dr. Batki is also conducting NIDA-funded research on the pharmacotherapy of methamphetamine dependence. Recently completed NIDA and NIAAA work has included the study of hepatitis C treatment in injection drug users and the pharmacological treatment of alcohol dependence in schizophrenia. Prior research has also focused on the treatment of opioid use disorders.

Dr. Batki also serves as Consulting Addiction Psychiatrist to Alta Mira Recovery Programs, a private substance use disorder residential rehabilitation program.


Problematic alcohol use and its impact on liver disease quality of life in a multicenter study of patients with cirrhosis.

Hepatology communications

Luk JW, Satre DD, Cheung R, Wong RJ, Monto A, Chen JY, Batki SL, Ostacher MJ, Snyder HR, Shui AM, Liao M, Haight CG, Khalili M

N-acetylcysteine for smoking cessation among dual users of tobacco and cannabis: Protocol and rationale for a randomized controlled trial.

Contemporary clinical trials

Herbst ED, Pennington DL, Borsari B, Manuel J, Yalch M, Alcid E, Martinez Rivas M, Delacruz J, Rossi N, Garcia B, Wong N, Batki SL

Rationale and design of a multisite randomized clinical trial examining an integrated behavioral treatment for veterans with co-occurring chronic pain and opioid use disorder: The pain and opioids integrated treatment in veterans (POSITIVE) trial.

Contemporary clinical trials

Vowles KE, Witkiewitz K, Clarke E, Schmidt Z, Borsari B, Edwards KE, Korecki JR, Moniz-Lewis DI, Bondzie JA, Mullins C, Thoreson CI, Delacruz J, Wilkins CH, Nelson S, Delventura J, Henderson R, Katz A, Hua W, Watson E, Baxley C, Canlas BR, Pendleton T, Herbst E, Batki S

Effects of buprenorphine on opioid craving in comparison to other medications for opioid use disorder: A systematic review of randomized controlled trials.

Addictive behaviors

Baxley C, Borsari B, Reavis JV, Manuel JK, Herbst E, Becker W, Pennington D, Batki SL, Seal K

Targeted Oral Naltrexone for Mild to Moderate Alcohol Use Disorder Among Sexual and Gender Minority Men: A Randomized Trial.

The American journal of psychiatry

Santos GM, Ikeda J, Coffin P, Walker J, Matheson T, Ali A, McLaughlin M, Jain J, Arenander J, Vittinghoff E, Batki S

Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial.


Oslin DW, Lynch KG, Shih MC, Ingram EP, Wray LO, Chapman SR, Kranzler HR, Gelernter J, Pyne JM, Stone A, DuVall SL, Lehmann LS, Thase ME, PRIME Care Research Group, Aslam M, Batki SL, Bjork JM, Blow FC, Brenner LA, Chen P, Desai S, Dieperink EW, Fears SC, Fuller MA, Goodman CS, Graham DP, Haas GL, Hamner MB, Helstrom AW, Hurley RA, Icardi MS, Jurjus GJ, Kilbourne AM, Kreyenbuhl J, Lache DJ, Lieske SP, Lynch JA, Meyer LJ, Montalvo C, Muralidhar S, Ostacher MJ, Paschall GY, Pfeiffer PN, Prieto S, Przygodzki RM, Ranganathan M, Rodriguez-Suarez MM, Roggenkamp H, Schichman SA, Schneeweis JS, Simonetti JA, Steinhauer SR, Suppes T, Umbert MA, Vassy JL, Voora D, Wiechers IR, Wood AE

Pilot study of extended-release lorcaserin for cocaine use disorder among men who have sex with men: A double-blind, placebo-controlled randomized trial.

PloS one

Santos GM, Ikeda J, Coffin P, Walker JE, Matheson T, McLaughlin M, Jain J, Vittinghoff E, Batki SL

Working memory and alcohol demand relationships differ according to PTSD symptom severity among veterans with AUD.

Experimental and clinical psychopharmacology

Abram SV, Batki SL, Pennington DL

Acute Cognitive Effects of the Hypocretin Receptor Antagonist Almorexant Relative to Zolpidem and Placebo: A Randomized Clinical Trial.


Neylan TC, Richards A, Metzler TJ, Ruoff LM, Varbel J, O'Donovan A, Sivasubramanian M, Motraghi T, Hlavin J, Batki SL, Inslicht SS, Samuelson K, Morairty SR, Kilduff TS

A randomized pilot trial of topiramate for alcohol use disorder in veterans with traumatic brain injury: Effects on alcohol use, cognition, and post-concussive symptoms.

Drug and alcohol dependence

Pennington DL, Bielenberg J, Lasher B, Herbst E, Abrams G, Novakovic-Agopian T, Batki SL

Effects of Mirtazapine for Methamphetamine Use Disorder Among Cisgender Men and Transgender Women Who Have Sex With Men: A Placebo-Controlled Randomized Clinical Trial.

JAMA psychiatry

Coffin PO, Santos GM, Hern J, Vittinghoff E, Walker JE, Matheson T, Santos D, Colfax G, Batki SL

Care of the Transgender Patient.

Annals of internal medicine

Herbst ED, Harris E, Pennington DL, Batki SL

Effects of oxytocin administration on cue-induced craving in co-occurring alcohol use disorder and PTSD: a within-participant randomized clinical trial.

Alcoholism, clinical and experimental research

Stauffer CS, Meinzer NK, Morrison T, Wen JH, Radanovich L, Leung D, Niles A, O'Donovan A, Batki SL, Woolley JD

Mobile Technology for Treatment Augmentation in Veteran Smokers With Posttraumatic Stress Disorder.

American journal of preventive medicine

Herbst E, Pennington D, Kuhn E, McCaslin SE, Delucchi K, Batki SL, Dickter B, Carmody T

Extended-release naltrexone for methamphetamine dependence among men who have sex with men: a randomized placebo-controlled trial.

Addiction (Abingdon, England)

Coffin PO, Santos GM, Hern J, Vittinghoff E, Santos D, Matheson T, Colfax G, Batki SL

Race/ethnicity, education, and age are associated with engagement in ecological momentary assessment text messaging among substance-using MSM in San Francisco.

Journal of substance abuse treatment

Turner CM, Coffin P, Santos D, Huffaker S, Matheson T, Euren J, DeMartini A, Rowe C, Batki S, Santos GM

Observational Evidence for Buprenorphine's Impact on Posttraumatic Stress Symptoms in Veterans With Chronic Pain and Opioid Use Disorder.

The Journal of clinical psychiatry

Seal KH, Maguen S, Bertenthal D, Batki SL, Striebel J, Stein MB, Madden E, Neylan TC

The effects of intranasal oxytocin in opioid-dependent individuals and healthy control subjects: a pilot study.


Woolley JD, Arcuni PA, Stauffer CS, Fulford D, Carson DS, Batki S, Vinogradov S

Feasibility, Acceptability, and Tolerability of Targeted Naltrexone for Nondependent Methamphetamine-Using and Binge-Drinking Men Who Have Sex with Men.

Journal of acquired immune deficiency syndromes (1999)

Santos GM, Coffin P, Santos D, Huffaker S, Matheson T, Euren J, DeMartini A, Rowe C, Hahn JA, Vlahov D, Vittinghoff E, Batki SL

Behavioral treatment of insomnia in early recovery.

Journal of addiction medicine

Kaplan KA, McQuaid J, Batki SL, Rosenlicht N

Topiramate treatment of alcohol use disorder in veterans with posttraumatic stress disorder: a randomized controlled pilot trial.

Alcoholism, clinical and experimental research

Batki SL, Pennington DL, Lasher B, Neylan TC, Metzler T, Waldrop A, Delucchi K, Herbst E

Varenicline treatment of concurrent alcohol and nicotine dependence in schizophrenia: a randomized, placebo-controlled pilot trial.

Journal of clinical psychopharmacology

Meszaros ZS, Abdul-Malak Y, Dimmock JA, Wang D, Ajagbe TO, Batki SL

Team-based learning exercise efficiently teaches brief intervention skills to medicine residents.

Substance abuse

Wamsley MA, Julian KA, O'Sullivan P, McCance-Katz EF, Batki SL, Satre DD, Satterfield J

Using standardized patients to evaluate screening, brief intervention, and referral to treatment (SBIRT) knowledge and skill acquisition for internal medicine residents.

Substance abuse

Satterfield JM, O'Sullivan P, Satre DD, Tsoh JY, Batki SL, Julian K, McCance-Katz EF, Wamsley M

Accuracy of self-reported medical problems in patients with alcohol dependence and co-occurring schizophrenia or schizoaffective disorder.

Schizophrenia research

Meszaros ZS, Dimmock JA, Ploutz-Snyder R, Chauhan SV, Abdul-Malak Y, Middleton FA, Batki SL

Predictors of smoking severity in patients with schizophrenia and alcohol use disorders.

The American journal on addictions

Meszaros ZS, Dimmock JA, Ploutz-Snyder RJ, Abdul-Malak Y, Leontieva L, Canfield K, Batki SL

Pharmacological approaches to methamphetamine dependence: a focused review.

British journal of clinical pharmacology

Karila L, Weinstein A, Aubin HJ, Benyamina A, Reynaud M, Batki SL

The description and evaluation of the implementation of an integrated healthcare model.

Families, systems & health : the journal of collaborative family healthcare

Funderburk JS, Sugarman DE, Maisto SA, Ouimette P, Schohn M, Lantinga L, Wray L, Batki S, Nelson B, Coolhart D, Strutynski K

Pregabalin treatment of anxiety in patients with substance use disorders.

The Annals of pharmacotherapy

Raza S, Siddiqui UA, Megna JL, Schwartz TL, Batki SL

Health-related quality of life in methadone maintenance patients with untreated hepatitis C virus infection.

Drug and alcohol dependence

Batki SL, Canfield KM, Smyth E, Ploutz-Snyder R

Patient and provider attitudes towards monitored naltrexone treatment of alcohol dependence in schizophrenia.

The American journal of drug and alcohol abuse

Leontieva L, Dimmock J, Cavallerano M, DeRycke S, Meszaros Z, Carey K, Ploutz-Snyder R, Batki SL

Medical comorbidity in patients with schizophrenia and alcohol dependence.

Schizophrenia research

Batki SL, Meszaros ZS, Strutynski K, Dimmock JA, Leontieva L, Ploutz-Snyder R, Canfield K, Drayer RA

Voucher-based incentives for naltrexone treatment attendance in schizophrenia and alcohol use disorders.

Psychiatric services (Washington, D.C.)

Leontieva L, Dimmock JA, Gately PW, Gallinger L, Ploutz-Snyder R, Batki SL

Pharmacological treatment of schizophrenia and co-occurring substance use disorders.

CNS drugs

Smelson DA, Dixon L, Craig T, Remolina S, Batki SL, Niv N, Owen R

Monitored naltrexone without counseling for alcohol abuse/dependence in schizophrenia-spectrum disorders.

The American journal on addictions

Batki SL, Dimmock JA, Wade M, Gately PW, Cornell M, Maisto SA, Carey KB, Ploutz-Snyder R

Adapting Motivational Interventions for Comorbid Schizophrenia and Alcohol Use Disorders.

Clinical psychology : a publication of the Division of Clinical Psychology of the American Psychological Association

Carey KB, Leontieva L, Dimmock J, Maisto SA, Batki SL

Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial.

Drug and alcohol dependence

Sorensen JL, Haug NA, Delucchi KL, Gruber V, Kletter E, Batki SL, Tulsky JP, Barnett P, Hall S

Rural jail telepsychiatry: a pilot feasibility study.

Telemedicine journal and e-health : the official journal of the American Telemedicine Association

Manfredi L, Shupe J, Batki SL

Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations.

Journal of psychiatric practice

Ziedonis DM, Smelson D, Rosenthal RN, Batki SL, Green AI, Henry RJ, Montoya I, Parks J, Weiss RD

Fluoxetine attenuates adrenocortical but not subjective responses to cocaine cues.

The American journal of drug and alcohol abuse

Harris DS, Batki SL, Berger SP

Comorbidity of bipolar disorder and substance abuse in Costa Rica: pedigree- and population-based studies.

Journal of affective disorders

Escamilla MA, Batki S, Reus VI, Spesny M, Molina J, Service S, Vinogradov S, Neylan T, Mathews C, Meza L, Gallegos A, Montero AP, Cruz ML, Neuhaus J, Roche E, Smith L, Leon P, Freimer NB

Genomewide linkage disequilibrium mapping of severe bipolar disorder in a population isolate.

American journal of human genetics

Ophoff RA, Escamilla MA, Service SK, Spesny M, Meshi DB, Poon W, Molina J, Fournier E, Gallegos A, Mathews C, Neylan T, Batki SL, Roche E, Ramirez M, Silva S, De Mille MC, Dong P, Leon PE, Reus VI, Sandkuijl LA, Freimer NB

Medical service use and financial charges among opioid users at a public hospital.

Drug and alcohol dependence

Masson CL, Sorensen JL, Batki SL, Okin R, Delucchi KL, Perlman DC

Urine toxicology samples in cocaine treatment trials: how many need to be tested?

Journal of addictive diseases

Delucchi KL, Batki SL, Moon J, Jacob P, Jones RT

Fine-scale mapping of a locus for severe bipolar mood disorder on chromosome 18p11.3 in the Costa Rican population.

Proceedings of the National Academy of Sciences of the United States of America

McInnes LA, Service SK, Reus VI, Barnes G, Charlat O, Jawahar S, Lewitzky S, Yang Q, Duong Q, Spesny M, Araya C, Araya X, Gallegos A, Meza L, Molina J, Ramirez R, Mendez R, Silva S, Fournier E, Batki SL, Mathews CA, Neylan T, Glatt CE, Escamilla MA, Luo D, Gajiwala P, Song T, Crook S, Nguyen JB, Roche E, Meyer JM, Leon P, Sandkuijl LA, Freimer NB, Chen H

Genome screening for linkage disequilibrium in a Costa Rican sample of patients with bipolar-I disorder: a follow-up study on chromosome 18.

American journal of medical genetics

Escamilla MA, McInnes LA, Service SK, Spesny M, Reus VI, Molina J, Gallegos A, Fournier E, Batki S, Neylan T, Matthews C, Vinogradov S, Roche E, Tyler DJ, Shimayoshi N, Mendez R, Ramirez R, Ramirez M, Araya C, Araya X, Leon PE, Sandkuijl LA, Freimer NB

Utility of routine drug screening in a psychiatric emergency setting.

Psychiatric services (Washington, D.C.)

Schiller MJ, Shumway M, Batki SL

Methamphetamine quantitative urine concentrations during a controlled trial of fluoxetine treatment. Preliminary analysis.

Annals of the New York Academy of Sciences

Batki SL, Moon J, Delucchi K, Bradley M, Hersh D, Smolar S, Mengis M, Lefkowitz E, Sexe D, Morello L, Everhart T, Jones RT, Jacob P

Patterns of substance use among patients in an urban psychiatric emergency service.

Psychiatric services (Washington, D.C.)

Schiller MJ, Shumway M, Batki SL

Stimulant psychosis: symptom profile and acute clinical course.

The American journal on addictions

Harris D, Batki SL

Substance abuse and HIV infection.

New directions for mental health services

Ferrando SJ, Batki SL

Assessing the feasibility of linkage disequilibrium methods for mapping complex traits: an initial screen for bipolar disorder loci on chromosome 18.

American journal of human genetics

Escamilla MA, McInnes LA, Spesny M, Reus VI, Service SK, Shimayoshi N, Tyler DJ, Silva S, Molina J, Gallegos A, Meza L, Cruz ML, Batki S, Vinogradov S, Neylan T, Nguyen JB, Fournier E, Araya C, Barondes SH, Leon P, Sandkuijl LA, Freimer NB

Medication adherence strategies for drug abusers with HIV/AIDS.

AIDS care

Sorensen JL, Mascovich A, Wall TL, DePhilippis D, Batki SL, Chesney M

Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial.

Addiction (Abingdon, England)

Ling W, Charuvastra C, Collins JF, Batki S, Brown LS, Kintaudi P, Wesson DR, McNicholas L, Tusel DJ, Malkerneker U, Renner JA, Santos E, Casadonte P, Fye C, Stine S, Wang RI, Segal D

Buprenorphine and naloxone interactions in methadone maintenance patients.

Biological psychiatry

Mendelson J, Jones RT, Welm S, Brown J, Batki SL

Measurement properties of quantitative urine benzoylecgonine in clinical trials research.

Addiction (Abingdon, England)

Delucchi KL, Jones RT, Batki SL

A complete genome screen for genes predisposing to severe bipolar disorder in two Costa Rican pedigrees.

Proceedings of the National Academy of Sciences of the United States of America

McInnes LA, Escamilla MA, Service SK, Reus VI, Leon P, Silva S, Rojas E, Spesny M, Baharloo S, Blankenship K, Peterson A, Tyler D, Shimayoshi N, Tobey C, Batki S, Vinogradov S, Meza L, Gallegos A, Fournier E, Smith LB, Barondes SH, Sandkuijl LA, Freimer NB

Psychiatric morbidity, illicit drug use and adherence to zidovudine (AZT) among injection drug users with HIV disease.

The American journal of drug and alcohol abuse

Ferrando SJ, Wall TL, Batki SL, Sorensen JL

A controlled trial of fluoxetine in crack cocaine dependence.

Drug and alcohol dependence

Batki SL, Washburn AM, Delucchi K, Jones RT

An approach to investigating linkage for bipolar disorder using large Costa Rican pedigrees.

American journal of medical genetics

Freimer NB, Reus VI, Escamilla M, Spesny M, Smith L, Service S, Gallegos A, Meza L, Batki S, Vinogradov S, Leon P, Sandkuijl LA

Genetic mapping using haplotype, association and linkage methods suggests a locus for severe bipolar disorder (BPI) at 18q22-q23.

Nature genetics

Freimer NB, Reus VI, Escamilla MA, McInnes LA, Spesny M, Leon P, Service SK, Smith LB, Silva S, Rojas E, Gallegos A, Meza L, Fournier E, Baharloo S, Blankenship K, Tyler DJ, Batki S, Vinogradov S, Weissenbach J, Barondes SH, Sandkuijl LA

Treatment outcomes for methadone clients receiving lump-sum payments at initiation of disability benefits.

Psychiatric services (Washington, D.C.)

Herbst MD, Batki SL, Manfredi LB, Jones T

Adherence to zidovudine (AZT) among HIV-infected methadone patients: a pilot study of supervised therapy and dispensing compared to usual care.

Drug and alcohol dependence

Wall TL, Sorensen JL, Batki SL, Delucchi KL, London JA, Chesney MA

Buspirone in drug users with AIDS or AIDS-related complex.

Journal of clinical psychopharmacology

Batki SL

Fluoxetine for cocaine abuse in methadone patients: preliminary findings.

NIDA research monograph

Batki SL, Manfredi LB, Sorensen JL, Jacob P, Dumontet R, Jones RT

Substance abuse and AIDS: the need for mental health services.

New directions for mental health services

Batki SL

Changes in needle sharing and syringe cleaning among San Francisco drug abusers.

The New England journal of medicine

Sorensen JL, Guydish J, Costantini M, Batki SL

HIV-infected i.v. drug users in methadone treatment: outcome and psychological correlates--a preliminary report.

NIDA research monograph

Batki SL, Sorensen JL, Gibson DR, Maude-Griffin P

Methadone maintenance program for AIDS-affected opiate addicts.

Journal of substance abuse treatment

Sorensen JL, Batki SL, Good P, Wilkinson K

Psychiatric aspects of treatment of i.v. drug abusers with AIDS.

Hospital & community psychiatry

Batki SL, Sorensen JL, Faltz B, Madover S

Psychiatric and ethical issues in the care of patients with AIDS.


Dilley JW, Shelp EE, Batki SL